日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term health benefit and economic return of time in range (TIR) improvement in individuals with type 2 diabetes

型糖尿病患者血糖达标时间 (TIR) 改善的长期健康益处和经济回报

Alkhuzam, Khalid; Li, Piaopiao; Abuloha, Sumaya; Xue, Qiaochu; Shi, Lizheng; Fonseca, Vivian; Zhang, Yongkang; Shao, Hui

Racial/Ethnic Disparities in Use of Angiotensin II Receptor Type 2/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA

美国高血压成人患者使用血管紧张素II受体2/4型刺激性降压药与抑制性降压药的种族/民族差异

Jafari, Eissa; Abuloha, Sumaya; Alshehri, Alaa; Eljilany, Islam; Aroza, Rupal; Guo, Jingchuan; Shao, Hui

An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022

对2008年至2022年美国癌症药物上市净价格、临床疗效和证据确定性进行分析

Abuloha, Sumaya; Harvey, Benjamin P; Niu, Shu; Alshehri, Alaa; Miri, Melissa; Clifford, Katherine; Chambers, James; Svensson, Mikael

Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period

过去十年间,联邦医疗保险D部分(Medicare Part D)的支出集中度及专科药品支出占比变化

Niu, Shu; Happe, Laura E; Abuloha, Sumaya; Svensson, Mikael